Our client needed help to define, validate, and launch its first portfolio of RWD and RWE life sciences offerings, including clinical trial design, outcomes research portfolio planning, FDA submission, reimbursement approval acceleration, and commercial sales acceleration.
The portfolio was designed, market-validated and launched. Time-to-close sales contracts was reduced 40%. Sales increased by multiples at customers like Roche, Amgen, and Pfizer. The firm is recognized as a global leader.